Abstract

BackgroundPatients with rheumatoid arthritis (RA) have increased risk of heart failure not explained by traditional cardiovascular risk factors. Even patients without clinical heart disease have a high prevalence of left...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Increased prevalence of diastolic dysfunction in rheumatoid arthritis
E Myasoedova ... S E Gabriel
Annals of the Rheumatic Diseases | VOL. 69
E Myasoedova, et. al.E Myasoedova ... S E Gabriel
24 May 2010
A cross‐sectional study of diastolic dysfunction in rheumatoid arthritis and its association with disease activity
Abo Malek Abdul Muizz ... Mohamed Said Mohd Shahrir
International Journal of Rheumatic Diseases | VOL. 14
Abo Malek Abdul Muizz, et. al.Abo Malek Abdul Muizz ... Mohamed Said Mohd Shahrir
24 Jan 2011
OP0164 Long-Term Blood Pressure Variability in Patients with Rheumatoid Arthritis (RA) Vs General Population, and its Impact on Cardiovascular Events and All-Cause Mortality in RA
...
Annals of the Rheumatic Diseases | VOL. 72
, et. al. ...
01 Jun 2013
The Impact of Different Classification Criteria Sets on the Estimated Prevalence and Associated Risk Factors of Diastolic Dysfunction in Rheumatoid Arthritis.
Gavin R Norton ... Chanel Robinson
International journal of rheumatology | VOL. 2017
Gavin R Norton, et. al.Gavin R Norton ... Chanel Robinson
01 Jan 2017
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers